• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Research Report on China Osteoporosis Drug Market, 2013-2017 Product Image

Research Report on China Osteoporosis Drug Market, 2013-2017

  • Published: November 2013
  • Region: China
  • 30 Pages
  • China Research & Intelligence

Osteoporosis is a systemic bone disease, a common disease among middle and old-aged people. It is characterized by low bone mineral density and deterioration of bone microarchitecture, which can lead to increased risks of fragility fracture. There are over 200 million osteoporosis patients around the world in the current stage. Regarding the genders of osteoporosis patients, the number of female patients is much larger than that of male patients, and the former are attacked by osteoporosis much earlier than the latter.

According to the data of Ministry of Civil Affairs of China, by the end of 2012, the population that were 60 years old and above was 193.9 million, taking up 14.3% of the total population; the population that were 65 years old and above was 127.14 million, taking up 9.4%. China has the largest old-aged population around the world, and the incidence rate of osteoporosis keeps increasing year after year. The number of patients diagnosed with osteoporosis in China is over 70 million, and the number of female patients is triple as much as that of male patients. 40%-50% patients are 60 years old or above, and about 25% patients have suffered fractures because of osteoporosis. READ MORE >

1 Basic Concepts of Osteoporosis
1.1 Definition and Classification
1.2 Clinic Manifestations
1.2.1 Pain
1.2.2 Deformation of Spinal Column
1.2.3 Fracture
1.3 Incidence Status
1.3.1 Incidence Status Worldwide
1.3.2 Incidence Status in China

2 Major Therapeutic Drugs of Osteoporosis
2.1 Bisphosphonates
2.2 Calcitonins
2.3 Estrogens
2.4 Parathyroid Hormones
2.5 Selective Estrogen Receptor Modulators
2.6 Strontium Salt
2.7 Activated Vitamin D and Analogues
2.8 Others

3 Osteoporosis Drug Market, 2008-2012
3.1 Global Market
3.1.1 Market Size
3.1.2 Global Competition Pattern of Osteoporosis Drugs
3.1.3 Competition Pattern of Pharmaceutical Enterprises
3.1.4 Key Varieties in Global Osteoporosis Drug Market

4 Analysis on Hospital Market of Osteoporosis Drugs in China, 2008-2012
4.1 Development Evironment
4.1.1 Economic and Medical Environment
4.1.2 Policy Environment
4.2 Market Size in China
4.3 Competition Pattern of Drug Varieties
4.4 Competition Pattern of Pharmaceutical Enterprises

5 Analysis on Major Competitive Varieties in China Osteoporosis Drug Market
5.1 Prices of Major Varieties
5.2 Sales Statuses of Major Varieties
5.3 Risks of Major Pharmaceutical Enterprises

6 Research and Development Status of Osteoporosis Drugs
6.1 Global Research and Development State and Trend of Osteoporosis Drugs
6.1.1 Global Research and Development Focuses of Osteoporosis Drugs
6.1.2 Global Osteoporosis Drugs Under Research
6.2 Research and Development State in China
6.2.1 Research and Development Focuses of Osteoporosis Drugs in China
6.2.2 Osteoporosis Drugs Under Research in China
6.2.3 Patents of Major Osteoporosis Drugs in China

7 Perspective of China Osteoporosis Drug Market, 2013-2017
7.1 Forecast on Supply
7.2 Forecast on Demand
7.3 Varieties Recommended
7.3.1 Potential Varieties Under Research
7.3.2 Varieties Launched Overseas but Unlaunched in China

Selected Charts

Chart Market Size of Global Osteoporosis Drug Industry, 2008-2012
Chart Competition Pattern of Global Osteoporosis Drug Market, 2012
Chart Market Size of Osteoporosis Drugs in China Hospital Market, 2008-2012
Chart Competition Pattern of Osteoporosis Drugs in China, 2012
Chart Sales Revenues of Major Osteoporosis Drugs in China, 2008-2012
Chart Research and Development Fields of Osteoporosis Drugs in China
Chart Forecast on Market Size of Osteoporosis Drugs in China, 2013-2017

Note: Product cover images may vary from those shown

ALSO AVAILABLE IN THE FOLLOWING LANGUAGES

RELATED PRODUCTS

Our Clients

Our clients' logos